Drug discovery

#Collaboration #Drug discovery #Partnership

The new industry partnerships fuelling innovation

Several new drug discovery collaboration agreements have recently been announced.  Entos Pharmaceuticals and Circio Circio Holding and Entos Pharmaceuticals have revealed plans to jointly develop Circio’s optimised circular RNA expression vectors (circVec) using the Entos Fusogenix PLV nucleic acid delivery technology.   Under the collaboration, Entos… Read More

#Business & Investment #News

Mount Sinai AI Center
#Artificial intelligence (AI) #Drug discovery #Icahn School of Medicine #New facility

Mount Sinai launches AI drug discovery centre

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, with the aim of harnessing artificial intelligence (AI) to revolutionise drug development.   The new Center will integrate AI with traditional drug discovery methods to identify and design new small-molecule therapeutics… Read More

#News

Ion channel modulators
#CNS #Drug discovery #Ion channel modulators #Therapeutic targets #Webinar

Last chance: Discover opportunities in ion channel drug discovery

Ion channels are often regarded as ‘difficult’ drug discovery targets, but this webinar, hosted by DDW and supported by Axxam, will provide data and insights showing that this negative perception is inaccurate and that there has been remarkable progress in bringing novel ion channel modulators into the clinic over the… Read More

Webinar date:
Supported by Axxam
#News

#Artificial intelligence (AI) #Drug discovery #Fundraising #Isomorphic Labs

Isomorphic Labs raises $600m to support AI drug design

Isomorphic Labs has raised $600 million towards its ambition to leverage AI to reimagine and accelerate drug discovery.   The financing round was led by Thrive Capital, with participation from GV, and follow-on capital from existing investor Alphabet.  Isomorphic Labs aims to apply its AI drug… Read More

#Business & Investment #News

Lab mouse
#Advertorial #Animal models #Drug discovery #Mouse models

Advancing drug discovery through next-generation mouse models

This advertorial for Taconic appeared in DDW Volume 26 – Issue 2, Spring 2025 Read the digital issue Taconic in vivo models provide enhanced physiological relevance for translational research. The NOG portfolio offers severely immunodeficient mice enabling engraftment of human hematopoietic stem cells (HSCs) to recapitulate features of the… Read More

#Exclusive Content

#Artificial intelligence (AI) #DDW Turning Science into Business Summit #Drug discovery #Events #Machine learning

‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery

Watch the DDW ‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery, to learn about the areas of opportunity for AI & ML in the drug discovery sector. The DDW ‘Turning Science into Business’ AI & ML summit sees experts and thought leaders in AI describe the… Read More

Webinar date:
Sponsored by The Jackson Laboratory
#Webinars

#AI / data analytics / healthtech / informatics #Biotech #DDW Turning Science into Business Summit #Drug discovery

Register now for DDW’s AI & ML summit

Hosted by Drug Discovery World and sponsored by The Jackson Laboratory, register now for the DDW ‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery, to learn about the areas of opportunity for AI & ML in the drug discovery sector. Taking place on 30 April,… Read More

#News

Drug discovery
#Artificial intelligence (AI) #Biotech #Cell analysis #Drug discovery #Flow Cytometry

The future direction and applications of flow cytometry

Miguel Tam, Director of Strategic Marketing at Revvity’s BioLegend, explores the future directions and applications of flow cytometry in drug discovery, highlighting the opportunities it presents and the challenges that lie ahead  Flow cytometry has long been a cornerstone in biomedical research and clinical diagnostics, offering unparalleled… Read More

#Exclusive Content

#Biotech #Business #China #Drug discovery #Funding

How has the biotech international market planning evolved

Sam Tomlinson, Vice President of Global Drug Safety at Arriello unpacks North America/EU research which compares today’s commercialisation strategies with those of five years ago.   As biotechs around the world look to new territories including emerging markets for their next returns, many are encountering unexpected hurdles. Too… Read More

#Exclusive Content

Ion channel modulators
#CNS #Drug discovery #Ion channel modulators #Therapeutic targets #Webinar

Discover why ion channels don’t have to be difficult drug discovery targets

Ion channels are often regarded as ‘difficult’ drug discovery targets, but this webinar, hosted by DDW and supported by Axxam, will provide data and insights showing that this negative perception is inaccurate and that there has been remarkable progress in bringing novel ion channel modulators into the clinic over the… Read More

Webinar date:
Supported by Axxam
#News

#Business #Drug discovery

Turning Science into Business Symposium (DDW)

The DDW Turning Science into Business Symposium will take place in the afternoon on Tuesday 4 November 2025 at the Francis Crick Institute, one of Europe’s biggest biomedical labs, in London, UK. This is a half day conference and will include a coffee/networking break.  Speakers from Cancer… Read More

Cell and gene therapy concept
#CSL Behring #Drug discovery #Gene therapy #Haemophilia

Gene therapy landmark in haemophilia B

Following the news that the first patients in Denmark with haemophilia B had been treated with Hemgenix (etranacogene dezaparvovec) gene therapy since European Commission approval, DDW’s Megan Thomas spoke with Dr Fredrik Sjöö, Head of Medical Affairs in the Nordic Region at CSL Behring, as well as Radovan Tomic, Global Market Access Director… Read More

#Exclusive Content

#Adverse event #Cancer research #CAR-T #Cardio #CRISPR #CRISPR-Cas9 #Drug discovery #Gene editing #Imaging #Oncology #Screening

New podcast: Innovation enabled by new drug discovery technologies

This is the latest episode of the free DDW narrated podcast, titled “Innovation enabled by new drug discovery technologies”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “CRISPR breakthroughs: New solutions for common diseases” and “Re-assessing the risks of… Read More

#News